- Q3 2023 Ocular Therapeutix Inc Earnings Call TranscriptNov 07, 2023$2.84 (+2.90%)Earnings
- Ocular Therapeutix Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2023$4.36 (-3.33%)Earnings
- Ocular Therapeutix Inc To Discuss the 12-Month Data TranscriptJun 12, 2023
- Ocular Therapeutix Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Ocular Therapeutix Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Ocular Therapeutix Inc Earnings Call TranscriptMay 08, 2023$6.4 (+2.40%)Earnings
- Q4 2022 Ocular Therapeutix Inc Earnings Call TranscriptMar 06, 2023$5.58 (-5.58%)Earnings
- Ocular Therapeutix Inc To Discuss Interim Data Update Call TranscriptFeb 13, 2023
- Q3 2022 Ocular Therapeutix Inc Earnings Call TranscriptNov 07, 2022$3.55 (+1.43%)Earnings
- Ocular Therapeutix Inc Corporate Call TranscriptSep 27, 2022
- Q2 2022 Ocular Therapeutix Inc Earnings Call TranscriptAug 08, 2022$5.06 (+2.02%)Earnings
- Q1 2022 Ocular Therapeutix Inc Earnings Call TranscriptMay 09, 2022$3.26 (-6.05%)Earnings
- Q4 2021 Ocular Therapeutix Inc Earnings Call TranscriptFeb 28, 2022$5.58 (+1.09%)Earnings
- Ocular Therapeutix Inc to Discuss Results From Its Phase 2 Clinical Trial of OTX-DED Call TranscriptDec 06, 2021
- Q3 2021 Ocular Therapeutix Inc Earnings Call TranscriptNov 08, 2021$7.1 (+1.87%)Earnings
- Q2 2021 Ocular Therapeutix Inc Earnings Call TranscriptAug 09, 2021$10.73 (+1.90%)Earnings
- Q1 2021 Ocular Therapeutix Inc Earnings Call TranscriptMay 05, 2021$16.56 (-0.96%)Earnings
- Q4 2020 Ocular Therapeutix Inc Earnings Call TranscriptMar 11, 2021$20.31 (+3.31%)Earnings
- Ocular Therapeutix Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q3 2020 Ocular Therapeutix Inc Earnings Call TranscriptNov 05, 2020$12 (-0.41%)Earnings
- Q2 2020 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2020$8.21 (-2.96%)Earnings
- Ocular Therapeutix Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Q1 2020 Ocular Therapeutix Inc Earnings Call TranscriptMay 08, 2020$5.97 (-10.09%)Earnings
- Ocular Therapeutix Inc - Announces Results Of Phase 3 Clinical Trial of Dextenza TranscriptApr 28, 2020
- Q4 2019 Ocular Therapeutix Inc Earnings Call TranscriptMar 12, 2020$4.29 (-19.81%)Earnings
- Q3 2019 Ocular Therapeutix Inc Earnings Call TranscriptNov 12, 2019$2.57 (-12.29%)Earnings
- Q2 2019 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2019$4.57 (-1.51%)Earnings
- Q1 2019 Ocular Therapeutix Inc Earnings Call TranscriptMay 10, 2019$3.68 (+0.55%)Earnings
- Ocular Therapeutix Inc Research & Development Day TranscriptMar 28, 2019
- Q4 2018 Ocular Therapeutix Inc Earnings Call TranscriptMar 07, 2019$4.38 (+1.86%)Earnings
Ocular Therapeutix Inc Research & Development Day Transcript
All right. Well, welcome, everyone, and welcome, everyone, on the webcast to the pipeline review for Ocular Therapeutix. It is a -- it's been a long, long winding road to get to where we are today, which is actually a very, very exciting moment in the company. We're about to launch our first product, our first pharma product, but we also have a tremendous pipeline behind that and a tremendous amount of opportunities that our platform brings us. So if you leave today with 2 thoughts, what I really hope that you'll think is, first of all, there's a lot of opportunity in this company, but the second is that they are focused on what they need to do. And we have the focus because we, like everyone else, are looking at the capital markets and the equity markets the way they are and realizing that the days of endless cash flow are probably over and that we need to be able to really generate our own cash flow in the very near term to be able to ensure that we're able to access the kind of capital we need in order to feed the pipeline we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)